OpenCitations

Impact of Tenofovir Alafenamide on Lipid Profiles in Chronic Hepatitis B Patients: Systematic Review and Meta‐Analysis

Journal of Medical Virology 97(4) (2025)

Ping‐Yu Hsu; Hui‐Chen Su; Mi‐Chia Ma; Chien‐An Chen; Sin‐Yi Yu; Yi‐Ming Hua

Tenofovir amibufenamide in chronic hepatitis B: Lipid changes and 144-week safety with tenofovir disoproxil fumarate-to-tenofovir amibufenamide switch

World Journal of Gastroenterology 31(26) (2025)

Zhi-Hao Zeng; Jin-Qing Liu; Min Zhang; Cai-Liang Qiu; Zhen-Yu Xu

Comparative Efficacy and Renal Safety of Entecavir and Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B: A Retrospective Cohort Study From Vietnam

Pharmacology Research & Perspectives 13(5) (2025)

Thong Duy Vo; Han Ngoc Gia Nguyen; Sang The Phan

Metabolic effects and cardiovascular disease risks of TDF or TAF in patients with chronic hepatitis B: a systematic review and meta-analysis

Frontiers in Pharmacology 16 (2025)

Yuan-Hai Zhou; Nan Cai; Yu-Xin Chen; Yong-Lu Su; Peng Hu

Tenofovir-alafenamide

Reactions Weekly 1906(1) (2022)

Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir

Annals of Hepatology 28(5) (2023)

Fa- Da Wang; Jing Zhou; Lan-Qing Li; Yu-Jing Li; Meng-Lan Wang; Ya-Chao Tao; Dong-Mei Zhang; Yong-Hong Wang; En-Qiang Chen

The Effects of the COVID-19 Pandemic on Clinical and Laboratory Follow-up of Patients Diagnosed With Chronic Hepatitis B: A Multicenter, Prospective, Observational Study

Hepatitis Monthly 22(1) (2022)

Fethiye Akgul; Yusuf Arslan; Mehmet Celik; Omer Karasahin; Mustafa Kemal Celen

Effects of first-line nucleot(s)ide analogues on lipid profiles in patients with chronic hepatitis B: a network meta-analysis

European Journal of Clinical Pharmacology 80(3) (2024)

Kexin Tong; Mingjing Chen; Danni Wang; Haifeng Dai; Jiayi Peng; Jia Zhang; Jiao Zhou; Yujiao Chang; Wenxiang Huang

Real-life data of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in the patients with chronic hepatitis B: a single-center experience

Anatolian Current Medical Journal 3(3) (2021)

Mustafa AKAR